{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:36:41Z","timestamp":1747175801156,"version":"3.40.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R15GM120702"],"award-info":[{"award-number":["R15GM120702"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1074\/jbc.ra119.009194","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:45:41Z","timestamp":1570754741000},"page":"17603-17611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-7236","authenticated-orcid":false,"given":"Divyabharathy","family":"Tsiros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey E.","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surenna","family":"Pecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-5616","authenticated-orcid":false,"given":"Matthew A.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.009194_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.009194_bib2","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1074\/jbc.270.19.11322","article-title":"VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells","volume":"270","author":"Cohen","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.009194_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","article-title":"VEGF-A and the induction of pathological angiogenesis","volume":"2","author":"Nagy","year":"2007","journal-title":"Annu. Rev. Pathol"},{"key":"10.1074\/jbc.RA119.009194_bib4","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.1074\/jbc.M114.627372","article-title":"Synergistic binding of vascular endothelial growth factor-A and its receptors to heparin selectively modulates complex affinity","volume":"290","author":"Teran","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.009194_bib5","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2015.0589","article-title":"Heparan sulfate and heparin interactions with proteins","volume":"12","author":"Meneghetti","year":"2015","journal-title":"J. R. Soc. Interface"},{"key":"10.1074\/jbc.RA119.009194_bib6","doi-asserted-by":"crossref","first-page":"17R","DOI":"10.1093\/glycob\/cwh051","article-title":"Interactions of heparin\/heparan sulfate with proteins: appraisal of structural factors and experimental approaches","volume":"14","author":"Powell","year":"2004","journal-title":"Glycobiology"},{"key":"10.1074\/jbc.RA119.009194_bib7","doi-asserted-by":"crossref","first-page":"a004952","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1074\/jbc.RA119.009194_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3174\/ajnr.A1987","article-title":"Bevacizumab (Avastin)","volume":"31","author":"Mukherji","year":"2010","journal-title":"Am. J. Neuroradiol"},{"key":"10.1074\/jbc.RA119.009194_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/107327481201900407","article-title":"Lessons learned from Avastin","volume":"19","author":"Mortimer","year":"2012","journal-title":"Cancer Control"},{"key":"10.1074\/jbc.RA119.009194_bib10","doi-asserted-by":"crossref","first-page":"a006577","DOI":"10.1101\/cshperspect.a006577","article-title":"Anti-VEGF therapies in the clinic","volume":"2","author":"Meadows","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1074\/jbc.RA119.009194_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10456-016-9515-8","article-title":"Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes","volume":"19","author":"MacDonald","year":"2016","journal-title":"Angiogenesis"},{"key":"10.1074\/jbc.RA119.009194_bib12","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1182\/blood-2007-12-125856","article-title":"Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization","volume":"112","author":"Kawamura","year":"2008","journal-title":"Blood"},{"key":"10.1074\/jbc.RA119.009194_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1538-7836.2008.03212.x","article-title":"Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice","volume":"7","author":"Meyer","year":"2009","journal-title":"J. Thromb. Haemost"},{"key":"10.1074\/jbc.RA119.009194_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bjophthalmol-2013-304019","article-title":"Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes","volume":"98","author":"Julien","year":"2014","journal-title":"Br. J. Ophthalmol"},{"key":"10.1074\/jbc.RA119.009194_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/bjophthalmol-2012-302308","article-title":"In vitro induction of protein complexes between bevacizumab, VEGF-A165, and heparin: explanation for deposits observed on endothelial veins in monkey eyes","volume":"97","author":"Julien","year":"2013","journal-title":"Br. J. Ophthalmol"},{"key":"10.1074\/jbc.RA119.009194_bib16","doi-asserted-by":"crossref","first-page":"57197","DOI":"10.18632\/oncotarget.11084","article-title":"The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance","volume":"7","author":"Alidzanovic","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA119.009194_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.RES.0000026420.22406.79","article-title":"Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity","volume":"91","author":"Wijelath","year":"2002","journal-title":"Circulation Res"},{"key":"10.1074\/jbc.RA119.009194_bib18","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1074\/jbc.M308482200","article-title":"pH regulates vascular endothelial growth factor binding to fibronectin a mechanism for control of extracellular matrix storage and release","volume":"279","author":"Goerges","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.009194_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jvs.2003.10.042","article-title":"Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells","volume":"39","author":"Wijelath","year":"2004","journal-title":"J. Vasc. Surg"},{"key":"10.1074\/jbc.RA119.009194_bib20","first-page":"4711","article-title":"The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain","volume":"24","author":"Martino","year":"2010","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA119.009194_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1091\/mbc.e09-07-0590","article-title":"Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action","volume":"21","author":"Ferrara","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.RA119.009194_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1091\/mbc.4.12.1317","article-title":"The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF","volume":"4","author":"Park","year":"1993","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.RA119.009194_bib23","first-page":"851","article-title":"A mechanism for modulation of cellular responses to VEGF: activation of the integrins","volume":"6","author":"Byzova","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.009194_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4161\/cc.7.3.5234","article-title":"Integrin affinity modulation in angiogenesis","volume":"7","author":"Mahabeleshwar","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.RA119.009194_bib25","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1016\/j.biomaterials.2013.04.050","article-title":"The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165","volume":"34","author":"Traub","year":"2013","journal-title":"Biomaterials"},{"key":"10.1074\/jbc.RA119.009194_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1247663","article-title":"Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing","volume":"343","author":"Martino","year":"2014","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.009194_bib27","doi-asserted-by":"crossref","first-page":"21683","DOI":"10.1073\/pnas.0902510106","article-title":"PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation","volume":"106","author":"Smith","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.009194_bib28","doi-asserted-by":"crossref","first-page":"34796","DOI":"10.1074\/jbc.M806692200","article-title":"A catalytic role of heparin within the extracellular matrix","volume":"283","author":"Mitsi","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.009194_bib29","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1021\/bi060974p","article-title":"Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites","volume":"45","author":"Mitsi","year":"2006","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.009194_bib30","doi-asserted-by":"crossref","first-page":"627674","DOI":"10.1155\/2015\/627674","article-title":"Anti-VEGF therapy and the retina: an update","volume":"2015","author":"Tah","year":"2015","journal-title":"J. Ophthalmol"},{"key":"10.1074\/jbc.RA119.009194_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.devcel.2016.03.015","article-title":"The complexity of translating anti-angiogenesis therapy from basic science to the clinic","volume":"37","author":"Ye","year":"2016","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.RA119.009194_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1074\/jbc.RA119.009194_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin\u00ae) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1074\/jbc.RA119.009194_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1074\/jbc.RA119.009194_bib35","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.RA119.009194_bib36","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0140-6736(97)90014-3","article-title":"Antiangiogenesis for cancer therapy","volume":"349","author":"Harris","year":"1997","journal-title":"Lancet"},{"key":"10.1074\/jbc.RA119.009194_bib37","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/jcp.25312","article-title":"Extracellular matrix stiffness controls VEGF signaling and processing in endothelial cells","volume":"231","author":"Sack","year":"2016","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/jbc.RA119.009194_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.RA119.009194_bib39","doi-asserted-by":"crossref","first-page":"19518","DOI":"10.1074\/jbc.M211208200","article-title":"Regulation of vascular endothelial growth factor binding and activity by extracellular pH","volume":"278","author":"Goerges","year":"2003","journal-title":"J. Biol. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820307493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820307493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.009194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T13:41:12Z","timestamp":1695303672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820307493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":39,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0021925820307493"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.009194","relation":{},"ISSN":["0021-9258"],"issn-type":[{"type":"print","value":"0021-9258"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.009194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Tsiros et al.","name":"copyright","label":"Copyright"}]}}